Prenatal and perinatal determinants of lung health and disease in early life: A national heart, lung, and blood instituteworkshop report

JAMA Pediatrics

Volumn 170, Issue 5, 2016, Pages

  Manuck, Tracy A ^a   Levy, Philip T ^b,c   Gyamfi Bannerman, Cynthia ^d   Jobe, Alan H ^e   Blaisdell, Carol J ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Atlantic Health   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULTHOOD; ARTICLE; CHILDHOOD; CONCEPTION; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HEALTH; HUMAN; LUNG; LUNG DEVELOPMENT; LUNG DISEASE; LUNG FUNCTION; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PREGNANCY DISORDER; PRIORITY JOURNAL; BREATHING MECHANICS; CHILD; CHILD DEVELOPMENT; CHILD HEALTH; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFANT; LUNG DISEASES; MALE; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASES; UNITED STATES;

CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; INFANT HEALTH; INFANT, NEWBORN; LUNG; LUNG DISEASES; MALE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESPIRATORY MECHANICS; RESPIRATORY TRACT DISEASES; UNITED STATES;

EID: 84965125322     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.4577     Document Type: Article

References (37)

1. Stern DA, MorganWJ,Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: A non-selective longitudinal cohort study. Lancet. 2007;370(9589): 758-764.
2. Stocks J, Hislop A, Sonnappa S. Early lung development: Lifelong effect on respiratory health and disease. Lancet Respir Med. 2013;1(9):728-742.
3. Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2):111-122.
4. Chan JYC, Stern DA, Guerra S,Wright AL, MorganWJ, Martinez FD. Pneumonia in childhood and impaired lung function in adults: A longitudinal study. Pediatrics. 2015;135(4):607-616.
5. Resch B, Paes B. Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev. 2011;87(suppl 1):S47-S49.
6. Kotecha SJ, Dunstan FD, Kotecha S. Long term respiratory outcomes of late preterm-born infants. Semin Fetal Neonatal Med. 2012;17(2):77-81.
7. Kruger SJ, Nagle SK, Couch MJ, Ohno Y, Albert M, Fain SB. Functional imaging of the lungs with gas agents. J Magn Reson Imaging. 2016;43(2):295-315.
8. Walkup LL, Tkach JA, Higano NS, et al. Quantitativemagnetic resonance imaging of bronchopulmonary dysplasia in the neonatal intensive care unit environment. Am J Respir Crit Care Med. 2015;192(10):1215-1222.
9. Raj JU, Aliferis C, Caprioli RM, et al. Genomics and proteomics of lung disease: Conference summary. Am J Physiol Lung Cell Mol Physiol. 2007; 293(1):L45-L51.
10. Hibbard JU, Wilkins I, Sun L, et al; Consortium on Safe Labor. Respiratory morbidity in late preterm births. JAMA. 2010;304(4):419-425.
11. Todisco T, de Benedictis FM, Iannacci L, et al. Mild prematurity and respiratory functions. Eur J Pediatr. 1993;152(1):55-58.
12. Gyamfi-Bannerman C, Ananth CV. Trends in spontaneous and indicated preterm delivery among singleton gestations in the United States, 2005-2012. Obstet Gynecol. 2014;124(6):1069-1074.
13. Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol. 2012;39(3):441-457.
14. Getahun D, Strickland D, Zeiger RS, et al. Effect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med. 2010;164(2):187-192.
15. Soudée S, Vuillemin L, Alberti C, et al. Fetal growth restriction is worse than extreme prematurity for the developing lung. Neonatology. 2014;106(4):304-310.
16. Lees C, Marlow N, Arabin B, et al; TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: Cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42(4):400-408.
17. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr. 2010;156 (4):532-536.
18. Mestan KK, Check J, Minturn L, et al. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. Placenta. 2014;35(8): 570-574.
19. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683.
20. Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: Linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012;302(1):L36-L46.
21. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957-963.
22. Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol. 2014;14(12):827-835.
23. Kallapur S, Presicce P, Rueda C, Jobe A, Chougnet C. Fetal immune response to chorioamnionitis. Semin Reprod Med. 2014;32(1): 56-67.
24. Aagaard K,Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra65.
25. Stout MJ, Conlon B, Landeau M, et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol. 2013;208(3): 226.e1-226.e7.
26. Pryhuber GS, Maitre NL, Ballard RA, et al; Prematurity and Respiratory Outcomes Program Investigators. Prematurity and Respiratory Outcomes Program (PROP): Study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States. BMC Pediatr. 2015;15:37.
27. Barker DJP. In utero programming of chronic disease. Clin Sci (Lond). 1998;95(2):115-128.
28. Pike KC, Davis SA, Collins SA, et al. Prenatal development is linked to bronchial reactivity: Epidemiological and animal model evidence. Sci Rep. 2014;4:4705.
29. Zana-Taieb E, Butruille L, Franco-MontoyaM-L, et al. Effect of two models of intrauterine growth restriction on alveolarization in rat lungs: Morphometric and gene expression analysis. PLoS One. 2013;8(11):e78326.
30. Song Y, Yu Y,Wang D, et al. Maternal high-fat diet feeding during pregnancy and lactation augments lung inflammation and remodeling in the offspring. Respir Physiol Neurobiol. 2015;207:1-6.
31. Dominguez-Salas P, Moore SE, Baker MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014;5:3746.
32. Proskocil BJ, Sekhon HS, Clark JA, et al. Vitamin C prevents the effects of prenatal nicotine on pulmonary function in newborn monkeys. Am J Respir Crit Care Med. 2005;171(9):1032-1039.
33. McEvoy CT, Schilling D, Clay N, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: A randomized clinical trial. JAMA. 2014;311(20): 2074-2082.
34. CheckleyW,West KP Jr,Wise RA, et al. Maternal vitamin A supplementation and lung function in offspring. N Engl J Med. 2010;362(19): 1784-1794.
35. Foong RE, Bosco A, Jones AC, et al. The effects of in utero vitamin D deficiency on airway smooth muscle mass and lung function. Am J Respir Cell Mol Biol. 2015;53(5):664-675.
36. Zosky GR, Hart PH, Whitehouse AJO, et al. Vitamin D deficiency at 16 to 20 weeks' gestation is associated with impaired lung function and asthma at 6 years of age. Ann Am Thorac Soc. 2014;11(4): 571-577.
37. Turner S, Prabhu N, Danielan P, et al. First-and second-trimester fetal size and asthma outcomes at age 10 years. Am J Respir Crit Care Med. 2011;184 (4):407-413.